Study into safety of common over-the-counter drugs reaches milestone

March 21, 2012

An international study into the safety of some of the most widely used medicines has reached a significant milestone by recruiting its 6,000th patient.

The SCOT study, involving researchers at The University of Nottingham, is comparing the safety of commonly prescribed, non‐steroidal anti‐inflammatory drugs (NSAIDs) which include ibuprofen (Brufen) and diclofenac (Voltarol). The study has now managed to recruit 6,000 patients and 685 GP practices to the study, across Scotland, England, Denmark and The Netherlands.

It is hoped the findings of the study could benefit millions of arthritis sufferers around the world.

Local principal investigator Professor Chris Hawkey of The University of Nottingham is running the SCOT study across Nottinghamshire, Derbyshire, Lincolnshire, Leicestershire and South Yorkshire, and is keen to continue recruitment to the SCOT study locally. So far, 70 GP practices and 650 patients are helping with this study in this region.

"This study is designed to answer an important scientific question, which has the potential to improve the care of the thousands of arthritis sufferers across the UK. It is the first large-scale safety study of its kind, and really will make a difference to future prescribing within primary care," said Professor Hawkey.

NSAIDS are the group of drugs most commonly prescribed to relieve the joint pains associated with arthritis. Often they do that job well, which is why they are so popular, with millions of prescriptions written across the UK every year for NSAIDs, not counting all those sold over‐the‐counter in pharmacies and shops. However, like all drugs, NSAIDs can have side effects. These include irritation of the digestive system and effects on blood pressure and the heart.

A more recent group of NSAIDs called 'Cox‐2 inhibitors' was developed, which have been shown to be less harsh on the digestive system than the most popular existing NSAIDs, leading to fewer stomach ulcers and bleeding.

The question to be answered by the SCOT study is whether one of these new drugs, Celecoxib (Celebrex) has similar or dissimilar effects on the cardiovascular system as the older drugs. The study formally tests the hypothesis that Celecoxib is no different from the older NSAIDs.

The current patent for Celecoxib expires in 2014, allowing the to be produced generically and sold at a significantly lower price, slashing the price the NHS has to pay. This is about the time that the SCOT study is due to publish its results.

The study is being led by The University of Dundee, which is aiming to secure continued funding to finish the study and publish the findings, allowing doctors and people with arthritis to make the best choice, not just for their joint pains but also for their general health.

The project is supported by nine other Universities across Scotland, England, Denmark and The Netherlands, having recently expanded to include The University of Oxford, and Kings College London.

Professor Tom MacDonald, chief investigator on the study and Director of the Medicines Monitoring Unit at the University of Dundee, said: "This information will be of great value to everyone who needs to take these drugs on a regular basis, which is millions of people around the world. The findings will allow doctors and people with arthritis to make the best choice, not just for their joint pains but also for their general health."

Professor MacDonald and the SCOT study steering committee, which is made up of leading international experts, hope further funding may be granted to the project to extend recruitment into 2014, allowing the generation of significant extra data.

Explore further: NSAIDs are effective for short-term relief of low-back pain

Related Stories

Ibuprofen linked to reduced risk of Alzheimer's disease

May 5, 2008

Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer’s disease, according to a study published in the May 6, 2008, issue of Neurology, the medical journal ...

New research to reduce drug side-effects

July 9, 2009

They are a group of drugs which millions of people rely on to keep pain at bay but they can have unwanted side-effects which are sometimes more serious than the original health problem. Now scientists at The University of ...

Study finds more gut reaction to arthritis drugs

September 1, 2011

Patients often take drugs to lower stomach acid and reduce the chances they will develop ulcers from taking their anti-inflammatory drugs for conditions such as arthritis, but the combination may be causing major problems ...

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.